News + Filings Transactions
|
Yeshwant Krishna
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 11/04/2022 | Verve Therapeutics, Inc. | | Sale | Common Stock | 243 | $32.90 | $8k | By GV 2019 L.P. | 11/04/2022 |
| 11/04/2022 | Verve Therapeutics, Inc. | | Sale | Common Stock | 650 | $31.99 | $20.8k | By GV 2019 L.P. | 11/04/2022 |
| 11/04/2022 | Verve Therapeutics, Inc. | | Sale | Common Stock | 47.7k | $31.12 | $1.5M | By GV 2019 L.P. | 11/04/2022 |
| 11/04/2022 | Verve Therapeutics, Inc. | | Other (disposition) | Common Stock | 48.6k | $0.00 | $0 | By GV 2017 L.P. | 11/04/2022 |
| 11/03/2022 | Verve Therapeutics, Inc. | | Other (disposition) | Common Stock | 49.6k | $0.00 | $0 | By GV 2017 L.P. | 11/02/2022 |
| 11/03/2022 | Verve Therapeutics, Inc. | | Sale | Common Stock | 22.3k | $32.32 | $720k | By GV 2019 L.P. | 11/02/2022 |
| 11/03/2022 | Verve Therapeutics, Inc. | | Sale | Common Stock | 25.5k | $33.14 | $846.2k | By GV 2019 L.P. | 11/02/2022 |
| 11/03/2022 | Verve Therapeutics, Inc. | | Sale | Common Stock | 1.8k | $33.84 | $59.4k | By GV 2019 L.P. | 11/02/2022 |
| 11/02/2022 | Verve Therapeutics, Inc. | | Other (disposition) | Common Stock | 28.7k | $0.00 | $0 | By GV 2017 L.P. | 11/02/2022 |
| 11/02/2022 | Verve Therapeutics, Inc. | | Sale | Common Stock | 9.4k | $34.78 | $325.1k | By GV 2019 L.P. | 11/02/2022 |
| 11/02/2022 | Verve Therapeutics, Inc. | | Sale | Common Stock | 10.4k | $36.28 | $376.3k | By GV 2019 L.P. | 11/02/2022 |
| 11/02/2022 | Verve Therapeutics, Inc. | | Sale | Common Stock | 8.9k | $36.78 | $328.4k | By GV 2019 L.P. | 11/02/2022 |
| 09/30/2022 | EQRx, Inc. | | Grant | Stock Option (Right to Buy) | 101k | $4.95 | $500k | | 09/30/2022 |
| 06/09/2022 | Verve Therapeutics, Inc. | | Grant | Stock Option (right to buy) | 15.5k | $14.04 | $217.6k | | 06/09/2022 |
| 06/21/2021 | Verve Therapeutics, Inc. | | Conversion | Common Stock | 6.3M | $0.00 | $0 | By GV 2017, L.P. | 06/21/2021 |
| 06/21/2021 | Verve Therapeutics, Inc. | | Conversion | Common Stock | 4M | $0.00 | $0 | By GV 2019 L.P. | 06/21/2021 |
| 06/21/2021 | Verve Therapeutics, Inc. | | Conversion | Common Stock | 443.3k | $0.00 | $0 | By GV 2019 L.P. | 06/21/2021 |
| 06/21/2021 | Verve Therapeutics, Inc. | | Conversion | Series A Preferred Stock | 58.5M | $0.00 | $0 | By GV 2017, L.P. | 06/21/2021 |
| 06/21/2021 | Verve Therapeutics, Inc. | | Conversion | Series A-2 Preferred Stock | 37.3M | $0.00 | $0 | By GV 2019 L.P. | 06/21/2021 |
| 06/21/2021 | Verve Therapeutics, Inc. | | Conversion | Series B Preferred Stock | 4.1M | $0.00 | $0 | By GV 2019 L.P. | 06/21/2021 |
| 07/31/2018 | Foundation Medicine, Inc. | FMI | Other | Common Stock | 5.8k | $137.00 | $792.7k | | 07/31/2018 |
| 06/18/2015 | Foundation Medicine, Inc. | FMI | Grant | Common Stock | 6k | $32.23 | $193.3k | | 06/18/2015 |
| 06/15/2015 | Foundation Medicine, Inc. | FMI | Sale | Common Stock | 114.5k | $32.33 | $3.7M | See footnotes | 06/11/2015 |
| 06/12/2015 | Foundation Medicine, Inc. | FMI | Sale | Common Stock | 53.6k | $33.72 | $1.8M | See footnotes | 06/11/2015 |
| 06/11/2015 | Foundation Medicine, Inc. | FMI | Sale | Common Stock | 15.7k | $35.14 | $552.9k | See footnotes | 06/11/2015 |
| 05/14/2015 | Foundation Medicine, Inc. | FMI | Sale | Common Stock | 8.6k | $38.57 | $331.7k | See footnotes | 05/14/2015 |
| 04/07/2015 | Foundation Medicine, Inc. | FMI | Other | Common Stock | 952.2k | $50.00 | $47.6M | See footnote | 04/07/2015 |
| 04/07/2015 | Foundation Medicine, Inc. | FMI | Other | Common Stock | 923.7k | $50.00 | $46.2M | See footnote | 04/07/2015 |
| 06/18/2014 | Foundation Medicine, Inc. | FMI | Grant | Stock Option (right to buy) | 13.4k | $24.21 | $324.1k | | 06/18/2014 |
| 06/13/2014 | Foundation Medicine, Inc. | FMI | Sale | Common Stock | 1.3M | $22.40 | $29.1M | See footnote. | 06/13/2014 |
|